Navigation Links
Z Trim Holdings, Inc. Announces Pricing of Public Offering of Common Stock and Warrants
Date:11/13/2013

MUNDELEIN, Ill., Nov. 13, 2013 /PRNewswire/ -- Z Trim Holdings, Inc. (OTC Markets: ZTHO – News), a bio-technology company providing value-added ingredients to a variety of industries, today announced the pricing of a registered public offering of up to 2,250,000 shares of common stock and warrants to purchase up to 1,687,500 shares of common stock.

For every share of common stock purchased in the public offering for $0.75 per share, each investor will also receive a warrant to purchase three-quarters (3/4) of a share of common stock. The warrants have an exercise price of $1.00 per full share and a term of exercise of five years. The offering is expected to close on or about November 18, 2013, subject to customary closing conditions.

Z Trim plans to use the net proceeds from the offering to fund working capital needs and other general corporate purposes, including for conducting research and development ("R&D"), hiring additional sales and R&D staff, and further protecting its intellectual property.

Maxim Group LLC is serving as the exclusive placement agent for the offering.

The securities described above were offered pursuant to a registration statement on Form S-1 (File No. 333-186577), which was declared effective by the United States Securities and Exchange Commission (the "SEC") on November 12, 2013 (the "Registration Statement"). This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. A prospectus relating to this offering will be filed and then copies may be obtained at the SEC's website at http://www.sec.gov or by request at Maxim Group LLC, 405 Lexington Avenue, New York, NY 10174.

ABOUT Z TRIM®

Z Trim Holdings, Inc. is a bio-technology company that owns existing, and has developed new, products and processes to make use of biomass for uses in the food and industrial markets.  The Company's food division currently sells a line of products to the food industry that can help food manufacturers reduce their costs and help them solve many production problems.  The Company's revolutionary technology provides value-added ingredients across virtually all food industry categories.  The Company's all-natural products, among other things, help to reduce fat and calories, add fiber, provide shelf-stability, prevent oil migration, and add binding capacity – all without degrading the taste and texture of the final food products.  Perhaps most significantly, Z Trim's products can help extend finished products, and thereby increase its customers' gross margins.  The Company's industrial division, opened in 2012, sells eco-friendly ingredients to oil drilling, hydraulic fracturing, petroleum coke, steel/aluminum, paper and other industries.  The Company's industrial ingredients are highly functional in applications for adhesives, binders, viscofiers and emulsifiers.

Forward-Looking Statements and Risk Factors

Certain statements in this press release are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements involve a number of risks, uncertainties and other factors that could cause actual results, performance or achievements of Z Trim Holdings to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Other factors, which could materially affect such forward-looking statements, can be found in our filings with the Securities and Exchange Commission at www.sec.gov, including risk factors relating to our history of operating losses, that our auditors have expressed substantial doubt regarding our ability to continue as a going concern, the fact that we may dilute existing shareholders through additional stock issuances, and our reliance on our intellectual property. Investors, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are only made as of the date of this press release and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.Contacts:Media:

Investor Relations:Angela Strickland

John Columbia(847) 549-6002

Legend Securities, Inc.mediarelations@ztrim.com

718-233-2677 TwitterFacebookLinkedIn
'/>"/>

SOURCE Z Trim Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Bacterin International Holdings, Inc. Schedules Fourth Quarter 2011 Financial Earnings Conference Call
2. Innophos Holdings, Inc. Reports First Quarter 2012 Results
3. China Pharma Holdings, Inc. to Report First Quarter of Fiscal Year 2012 Financial Results on May 15, 2012
4. Inclinix-PMG Holdings, Inc. Announces Executive Management Changes
5. Organovo Holdings, Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
6. Aveka Nutra Processing proudly begins producing products from Z Trim Holdings, Inc.
7. Organovo Holdings, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
8. Z Trim Holdings, Inc. adds non-GMO corn products to its product line
9. Z Trim Holdings, Inc. Enters into Joint Development Agreement with Drilling Fluids Company
10. Z Trim Holdings, Inc. Records First Non-GMO Corn Sales
11. CTD Holdings, Inc. Announces Refinancing of Long Term Debt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology:
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
Breaking Biology News(10 mins):